Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason D Barbour

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Cell Host & Microbe|October 22, 2013
HIV-1 Vif adaptation to human APOBEC3H haplotypesMarcel Ooms, Bonnie Brayton, Michael Letko, et al.
Journal of Virology|October 9, 2002
Evolution of phenotypic drug susceptibility and viral replication capacity during long-term virologic failure of protease inhibitor therapy in human immunodeficiency virus-infected adultsJason D Barbour, Terri Wrin, Robert M Grant, et al.
Journal of Virology|December 13, 2003
Human immunodeficiency virus type 1 superinfection was not detected following 215 years of injection drug user exposureRose Tsui, Belinda L Herring, Jason D Barbour, et al.
Journal of Virology|March 23, 2007
Human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T(EMRA) cells in early infection are linked to control of HIV-1 viremia and predict the subsequent viral load set pointJohn W Northfield, Christopher P Loo, Jason D Barbour, et al.
Journal of Virology|February 29, 2008
Conferral of enhanced natural killer cell function by KIR3DS1 in early human immunodeficiency virus type 1 infectionBrian R Long, Lishomwa C Ndhlovu, Jorge R Oksenberg, et al.
The Journal of Infectious Diseases|October 20, 2005
Higher frequency of HIV-1-specific T cell immune responses in African American children vertically infected with HIV-1Elizabeth R Sharp, Jason D Barbour, R Karl Karlsson, et al.
Plos One|February 10, 2009
High CD8+ T cell activation marks a less differentiated HIV-1 specific CD8+ T cell response that is not altered by suppression of viral replicationJason D Barbour, Lishomwa C Ndhlovu, Qi Xuan Tan, et al.
Hawai'I Journal of Medicine & Public Health : a Journal of Asia Pacific Medicine & Public Health|September 21, 2013
Albuminuria as a marker of cardiovascular risk in HIV-infected individuals receiving stable antiretroviral therapyChawat Tongma, Cecilia M Shikuma, Beau K Nakamoto, et al.
AIDS (London, England)|July 29, 2004
Persistence of primary drug resistance among recently HIV-1 infected adultsJason D Barbour, Frederick M Hecht, Terri Wrin, et al.
AIDS (London, England)|May 11, 2002
Increased thymic mass and circulating naive CD4 T cells in HIV-1-infected adults treated with growth hormoneLaura A Napolitano, Joan C Lo, Michael B Gotway, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Cell Host & Microbe|October 22, 2013
HIV-1 Vif adaptation to human APOBEC3H haplotypesMarcel Ooms, Bonnie Brayton, Michael Letko, et al.
Journal of Virology|October 9, 2002
Evolution of phenotypic drug susceptibility and viral replication capacity during long-term virologic failure of protease inhibitor therapy in human immunodeficiency virus-infected adultsJason D Barbour, Terri Wrin, Robert M Grant, et al.
Journal of Virology|December 13, 2003
Human immunodeficiency virus type 1 superinfection was not detected following 215 years of injection drug user exposureRose Tsui, Belinda L Herring, Jason D Barbour, et al.
Journal of Virology|March 23, 2007
Human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T(EMRA) cells in early infection are linked to control of HIV-1 viremia and predict the subsequent viral load set pointJohn W Northfield, Christopher P Loo, Jason D Barbour, et al.
Journal of Virology|February 29, 2008
Conferral of enhanced natural killer cell function by KIR3DS1 in early human immunodeficiency virus type 1 infectionBrian R Long, Lishomwa C Ndhlovu, Jorge R Oksenberg, et al.
The Journal of Infectious Diseases|October 20, 2005
Higher frequency of HIV-1-specific T cell immune responses in African American children vertically infected with HIV-1Elizabeth R Sharp, Jason D Barbour, R Karl Karlsson, et al.
Plos One|February 10, 2009
High CD8+ T cell activation marks a less differentiated HIV-1 specific CD8+ T cell response that is not altered by suppression of viral replicationJason D Barbour, Lishomwa C Ndhlovu, Qi Xuan Tan, et al.
Hawai'I Journal of Medicine & Public Health : a Journal of Asia Pacific Medicine & Public Health|September 21, 2013
Albuminuria as a marker of cardiovascular risk in HIV-infected individuals receiving stable antiretroviral therapyChawat Tongma, Cecilia M Shikuma, Beau K Nakamoto, et al.
AIDS (London, England)|July 29, 2004
Persistence of primary drug resistance among recently HIV-1 infected adultsJason D Barbour, Frederick M Hecht, Terri Wrin, et al.
AIDS (London, England)|May 11, 2002
Increased thymic mass and circulating naive CD4 T cells in HIV-1-infected adults treated with growth hormoneLaura A Napolitano, Joan C Lo, Michael B Gotway, et al.
Pageof 5